aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Quartet Medicine is dedicated to innovating novel treatments for chronic pain and inflammation. The company focuses on developing non-opioid medications, addressing a significant need for safer pain management solutions. Their research and development efforts aim to provide effective alternatives to traditional pain relief methods.
Quartet Medicine has made significant strides in the biopharmaceutical industry, contributing to the advancement of non-opioid pain treatments. Their work has the potential to impact millions of patients suffering from chronic pain, offering safer and more effective therapeutic options.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Pain Medications
Technology
Biotech
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Quartet Medicine founded?
Quartet Medicine was founded in 2013.
Where is Quartet Medicine's headquarters located?
Quartet Medicine's headquarters is located in Cambridge, MA, US.
When was Quartet Medicine's last funding round?
Quartet Medicine's most recent funding round was for $6M (USD) in October 2015.
How many employees does Quartet Medicine have?
Quartet Medicine has 7 employees as of Feb 4, 2024.
How much has Quartet Medicine raised to-date?
As of July 05, 2023, Quartet Medicine has raised a total of $23M (USD) since Oct 7, 2015.
Add Comparison
Total Raised to Date
$23M
USD
Last Update Oct 7, 2015
Last Deal Details
$6M
USD
Oct 7, 2015
Series A
Total Employees Over Time
7
As of Feb 2024
Quartet Medicine Address
25 First St.
Suite 303
Cambridge,
Massachusetts
02141
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts